Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 25;9(3):3958-3965.
doi: 10.19082/3958. eCollection 2017 Mar.

Assessment of refractive outcome of femtosecond-assisted LASIK for hyperopia correction

Affiliations

Assessment of refractive outcome of femtosecond-assisted LASIK for hyperopia correction

Mohamed Tarek El-Naggar et al. Electron Physician. .

Abstract

Introduction: Laser vision correction for hyperopia is challenging. The purpose of the study was to assess the refractive outcomes of femtosecond-assisted laser in situ keratomileusis (LASIK) for hyperopic correction using wavefront-optimized ablation profiles.

Methods: This retrospective case series study included 20 Egyptian patients (40 eyes) with hyperopia or hyperopic astigmatism with a mean manifest refraction spherical equivalent (MRSE) of +2.55D±1.17 (range from +1.00 to +6.00) who had uneventful femtosecond-a assisted LASIK with wavefront-optimized aspheric ablation profile using refractive surgery suite (WaveLight FS200 Femtosecond Laser and WaveLight EX500 Excimer Laser) performed in the Research Institute of Ophthalmology and International Eye Hospital, Giza, Egypt. Statistical analysis was done using Microsoft Excel (Microsoft Corporation, Seattle, WA, USA).

Results: The procedure significantly reduced the MRSE and cylinder post-operatively (95% were ± 0.50D and 100% ± 1.00 D), with stability of refraction and UDVA over the follow-up period (up to 12 months) after surgery. No eye lost any line of the CDVA, which reflects the excellent safety profile of the procedure; on the other hand, one eye (5%) gained one line and one eye (5%) even gained two lines. There were no significant complications during the procedure.

Conclusions: Femtosecond-assisted laser in situ keratomileusis for hyperopia showed predictable, effective, and safe refractive outcomes that were stable through 12 months. Longer follow-up period is required to detect any further regression.

Keywords: Femtosecond LASIK; Hyperopia correction; Refractive outcomes; Refractive surgery.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There is no conflict of interest to be declared.

Figures

Figure 1
Figure 1
Preoperative CDVA (RED) compared with 12 months’ postoperative UDVA
Figure 2
Figure 2
The change of the CDVA 12 months postoperatively
Figure 3
Figure 3
Scattergram comparing achieved spherical equivalent refraction 12 months’ postoperatively (Y axis) and attempted spherical equivalent refraction (X axis)
Figure 4
Figure 4
Refractive accuracy expressed in postoperative spherical equivalent
Figure 5
Figure 5
Twelve months’ postoperative astigmatism (blue) compared to preoperative astigmatism (red)
Figure 6
Figure 6
Stability over 12 months’ follow-up

References

    1. Sher NA. Hyperopic refractive surgery. Curr Opin Ophthalmol. 2001;12(4):304–8. doi: 10.1097/00055735-200108000-00011. - DOI - PubMed
    1. O’Brart DP. The status of hyperopic laser-assisted in situ keratomileusis. Curr Opin Ophthalmol. 1999;10(4):247–52. doi: 10.1097/00055735-199908000-00005. - DOI - PubMed
    1. Suarez E, Torres F, Duplessie M. LASIK for correction of hyperopia and hyperopia with astigmatism. Int Ophthalmol Clin. 1996;36(4):65–72. doi: 10.1097/00004397-199603640-00010. - DOI - PubMed
    1. Esquenazi S. Five-year follow-up of laser in situ keratomileusis for hyperopia using the Technolas Keracor 117C excimer laser. J Refract Surg. 2004;20(4):356–63. - PubMed
    1. Zadok D, Raifkup F, Landau D, Frucht-Pery J. Long-term evaluation of hyperopic laser in situ keratomileusis. J Cataract Refract Surg. 2003;29(11):2181–8. doi: 10.1016/S0886-3350(03)00416-4.. - DOI - PubMed

LinkOut - more resources